Atlas Capital Advisors’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-953
Closed -$111K 954
2021
Q2
$111K Hold
953
0.02% 441
2021
Q1
$105K Buy
+953
New +$103K 0.02% 413
2019
Q3
Sell
-916
Closed -$71.3K 655
2019
Q2
$71.3K Sell
916
-56
-6% -$4.25K 0.02% 441
2019
Q1
$73.8K Sell
972
-487
-33% -$38.7K 0.03% 387
2018
Q4
$107K Sell
1,459
-603
-29% -$48.1K 0.04% 330
2018
Q3
$201K Buy
2,062
+56
+3% +$5.55K 0.07% 285
2018
Q2
$202K Sell
2,006
-74
-4% -$7.81K 0.07% 267
2018
Q1
$220K Buy
+2,080
New +$210K 0.07% 276

Other funds holding EMN

Atlas Capital Advisors's EMN Position: Q3 2021 in Review

Atlas Capital Advisors sold out of Eastman Chemical (EMN) in Q3 2021, closing a stake of 953 shares — an estimated $111K sold.

Atlas Capital Advisors first reported a position in EMN in Q1 2018 and held it in 8 quarters. The position peaked at $220K in Q1 2018. 706 funds tracked by Wall St. Rank hold EMN as of Q3 2021.

  • Atlas Capital Advisors reported no remaining Eastman Chemical position as of Q3 2021 after selling out during the quarter.
  • Atlas Capital Advisors sold 953 Eastman Chemical shares in Q3 2021, an estimated $111K.
  • Atlas Capital Advisors first reported a position in Eastman Chemical in Q1 2018 and held it in 8 quarters.
  • Atlas Capital Advisors's Eastman Chemical position peaked at $220K in Q1 2018.
  • 706 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2021.

Based on Atlas Capital Advisors's 13F filing for Q3 2021, filed 28 Oct 2021.